FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092165713> ?p ?o ?g. }

• W2092165713 abstract "The decision to treat breast cancer patients with Trastuzumab is based on HER2 receptor over-expression or gene amplification. However, even in this selective group of patients, the response rate remains poor and unpredictable. Furthermore, all responders eventually become resistant if Trastuzumab is given as monotherapy. It is still poorly understood how Trastuzumab exerts its mechanism of action and how the acquired resistance to this drug occurs. We have found the molecular mechanisms whereby Trastuzumab fails to abolish HER2 phosphorylation despite being an anti-HER2 monoclonal antibody and have resolved the inconsistencies in the literature regarding the effect of Trastuzumab on HER2 phosphorylation. Trastuzumab did not decrease HER2 phosphorylation in these cells despite the effect on HER2 receptor downregulation. HER2 phosphorylation was maintained by activation of EGFR, HER3 and HER4 via their dimerisation with HER2. The activation of EGFR, HER3 and HER4 was due to an upregulation of HER ligands including heregulin and betacellulin. The upregulation of HER ligands was mediated by ADAM17 through a PKB negative feedback loop. The feedback loop was activated because of the inhibition of PKB by Trastuzumab treatment since upregulation of HER ligands and ADAM17 also occurred when PKB phosphorylation was inhibited by a PKB inhibitor (Akt inhibitor VIII, Akti-1/2). However, the combination treatment of Trastuzumab with a panHER inhibitor JNJ-26483327 was able to abrogate the feedback loop and it was synergistic in tumour inhibition in a BT474 xenograft model. Our data provides evidence that Trastuzumab resistance can be mediated by activation of HER family ligands as a direct consequence of inhibition of HER2 and PKB signalling. This offers treatment opportunities for overcoming resistance in these patients, including approaches to target all HER receptors in combination with Trastuzumab treatment. Future research should utilize a systems biology approach to identify other feedback loops that may be involved in the acquired resistance to Trastuzumab treatment in HER2 positive breast cancer. Citation Information: Clin Cancer Res 2010;16(7 Suppl):A10" @default.
• W2092165713 created "2016-06-24" @default.
• W2092165713 creator A5000996602 @default.
• W2092165713 creator A5002070840 @default.
• W2092165713 creator A5012602285 @default.
• W2092165713 creator A5018411240 @default.
• W2092165713 creator A5032296324 @default.
• W2092165713 creator A5036009351 @default.
• W2092165713 creator A5078343883 @default.
• W2092165713 date "2010-04-01" @default.
• W2092165713 modified "2023-09-27" @default.
• W2092165713 title "Abstract A10: Upregulation of ADAM17 protease and HER ligands through a PKB negative feedback loop mediates acquired resistance to Trastuzumab in HER2 overexpressed breast cancer" @default.
• W2092165713 doi "https://doi.org/10.1158/1078-0432.tcme10-a10" @default.
• W2092165713 hasPublicationYear "2010" @default.
• W2092165713 type Work @default.
• W2092165713 sameAs 2092165713 @default.
• W2092165713 citedByCount "0" @default.
• W2092165713 crossrefType "proceedings-article" @default.
• W2092165713 hasAuthorship W2092165713A5000996602 @default.
• W2092165713 hasAuthorship W2092165713A5002070840 @default.
• W2092165713 hasAuthorship W2092165713A5012602285 @default.
• W2092165713 hasAuthorship W2092165713A5018411240 @default.
• W2092165713 hasAuthorship W2092165713A5032296324 @default.
• W2092165713 hasAuthorship W2092165713A5036009351 @default.
• W2092165713 hasAuthorship W2092165713A5078343883 @default.
• W2092165713 hasConcept C104317684 @default.
• W2092165713 hasConcept C11960822 @default.
• W2092165713 hasConcept C121608353 @default.
• W2092165713 hasConcept C126322002 @default.
• W2092165713 hasConcept C127561419 @default.
• W2092165713 hasConcept C185592680 @default.
• W2092165713 hasConcept C2779786085 @default.
• W2092165713 hasConcept C502942594 @default.
• W2092165713 hasConcept C530470458 @default.
• W2092165713 hasConcept C55493867 @default.
• W2092165713 hasConcept C71924100 @default.
• W2092165713 hasConcept C75217442 @default.
• W2092165713 hasConcept C86803240 @default.
• W2092165713 hasConcept C95444343 @default.
• W2092165713 hasConceptScore W2092165713C104317684 @default.
• W2092165713 hasConceptScore W2092165713C11960822 @default.
• W2092165713 hasConceptScore W2092165713C121608353 @default.
• W2092165713 hasConceptScore W2092165713C126322002 @default.
• W2092165713 hasConceptScore W2092165713C127561419 @default.
• W2092165713 hasConceptScore W2092165713C185592680 @default.
• W2092165713 hasConceptScore W2092165713C2779786085 @default.
• W2092165713 hasConceptScore W2092165713C502942594 @default.
• W2092165713 hasConceptScore W2092165713C530470458 @default.
• W2092165713 hasConceptScore W2092165713C55493867 @default.
• W2092165713 hasConceptScore W2092165713C71924100 @default.
• W2092165713 hasConceptScore W2092165713C75217442 @default.
• W2092165713 hasConceptScore W2092165713C86803240 @default.
• W2092165713 hasConceptScore W2092165713C95444343 @default.
• W2092165713 hasLocation W20921657131 @default.
• W2092165713 hasOpenAccess W2092165713 @default.
• W2092165713 hasPrimaryLocation W20921657131 @default.
• W2092165713 hasRelatedWork W1544749943 @default.
• W2092165713 hasRelatedWork W1734411634 @default.
• W2092165713 hasRelatedWork W1914623042 @default.
• W2092165713 hasRelatedWork W1989116686 @default.
• W2092165713 hasRelatedWork W1997056190 @default.
• W2092165713 hasRelatedWork W2009763382 @default.
• W2092165713 hasRelatedWork W2011709484 @default.
• W2092165713 hasRelatedWork W2051051838 @default.
• W2092165713 hasRelatedWork W2056021046 @default.
• W2092165713 hasRelatedWork W2090237134 @default.
• W2092165713 hasRelatedWork W2103746415 @default.
• W2092165713 hasRelatedWork W2109284739 @default.
• W2092165713 hasRelatedWork W2216779694 @default.
• W2092165713 hasRelatedWork W2313077067 @default.
• W2092165713 hasRelatedWork W2396317271 @default.
• W2092165713 hasRelatedWork W2565658677 @default.
• W2092165713 hasRelatedWork W2726595065 @default.
• W2092165713 hasRelatedWork W2772424151 @default.
• W2092165713 hasRelatedWork W2803726086 @default.
• W2092165713 hasRelatedWork W2887612026 @default.
• W2092165713 isParatext "false" @default.
• W2092165713 isRetracted "false" @default.
• W2092165713 magId "2092165713" @default.
• W2092165713 workType "article" @default.